Clinical Trial Update: The Role Of FGF23, Klotho, And Sclerostin In Kidney Stone Formers

View source ↗

Summary

A clinical trial update examining the roles of FGF23, Klotho, and sclerostin in individuals with nephrolithiasis (kidney stones).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrolithiasis

Snippet

Sponsor: University of Zurich | Conditions: Kidney Stones | Status: UNKNOWN